Innate and adaptive immune recognition pathways

Innate and adaptive immune recognition pathways represent the integrated systems used by organisms to distinguish self from non-self and identify potential threats. The innate pathway provides an immediate, non-specific response through pattern recognition receptors (PRRs) that detect conserved microbial features (Janeway & Medzhitov, 2002, Annu. Rev. Immunol.). The adaptive pathway offers a delayed but highly specific response, utilizing somatically rearranged receptors on T and B lymphocytes to recognize unique antigenic peptides (Murphy & Weaver, 2016, Janeway's Immunobiology). These pathways are essential for host defense against pathogens and the surveillance of malignant cells, but their chronic activation or failure to maintain self-tolerance leads to inflammatory and autoimmune disorders (Akira et al., 2006, Cell). Because these pathways involve hundreds of distinct proteins, they are not considered a single therapeutic target; rather, they contain numerous individual targets such as Toll-like receptors, kinases, and checkpoint molecules (Kaufmann et al., 2019, Nat. Rev. Drug Discov.). Pharmacological agents targeting these pathways include vaccines, monoclonal antibodies, and small-molecule inhibitors designed to either stimulate or dampen the immune response depending on the clinical context. Consequently, while these pathways are the foundation of immunology, drug development focuses on specific molecular nodes within them to achieve therapeutic precision.

Other names

Immune recognitionInnate immunityAdaptive immunityPattern recognition pathwaysAntigen recognition pathwaysImmune signaling

Modulation of various receptors, kinases, and transcription factors within the immune system to either stimulate or suppress immune activity.